Burning Foot Pain in a 68-year-old Man with Diabetes: Red Flag?

In the context of this patient's overall health, which follow-up studies should his presenting symptom prompt?

Recent Content

The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.

Evidence to date is conflicting on the potential role of antihyperglycemic drugs, old and new, in cardioprotection. Results reported here add to the pool and fuel ongoing study.

The sodium glucose cotransporter-2 inhibitors have many advantages eg, modest A1c reduction and low hypoglycemia risk. But careful patient selection is critical.

Optimizing the use of insulin for treatment of hyperglycemia in patients with diabetes is an ongoing research endeavor. Here, several recent developments you should know about.

A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?

Those friendly reminders; you get them every day--Mrs X hasn't refilled a scrip; Mr J needs an eye exam; Ms Q may be noncompliant with her ARB. Listen, I promise I DO know what the guidelines say!

This is the first in a series of studies to determine if the longer, flatter action profile of U300 insulin glargine (vs U100 glargine) will result in less hypoglycemia, and especially nocturnal events.

By clicking Accept, you agree to become a member of the UBM Medica Community.